Roubin GS - Search Results

1

Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion.

Ellis SG, Shaw RE, Gershony G, Thomas R, Roubin GS, Douglas JS Jr, Topol EJ, Startzer SH, Myler RK, King SB 3rd. Ellis SG, et al. Among authors: roubin gs. Am J Cardiol. 1989 Apr 15;63(13):897-901. doi: 10.1016/0002-9149(89)90135-5. Am J Cardiol. 1989. PMID: 2522727 Free article.

2

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.

Hearn JA, Donohue BC, Ba'albaki H, Douglas JS, King SB 3rd, Lembo NJ, Roubin GS, Sgoutas DS. Hearn JA, et al. Among authors: roubin gs. Am J Cardiol. 1992 Mar 15;69(8):736-9. doi: 10.1016/0002-9149(92)90497-m. Am J Cardiol. 1992. PMID: 1532112

3

Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settings.

Ellis SG, Myler RK, King SB 3rd, Douglas JS Jr, Topol EJ, Shaw RE, Stertzer SH, Roubin GS, Murphy MC. Ellis SG, et al. Among authors: roubin gs. Am J Cardiol. 1991 Dec 1;68(15):1447-51. doi: 10.1016/0002-9149(91)90277-r. Am J Cardiol. 1991. PMID: 1746425

4

Effects of nonionic versus ionic contrast media on complications of percutaneous transluminal coronary angioplasty.

Lembo NJ, King SB 3rd, Roubin GS, Black AJ, Douglas JS Jr. Lembo NJ, et al. Among authors: roubin gs. Am J Cardiol. 1991 May 15;67(13):1046-50. doi: 10.1016/0002-9149(91)90863-g. Am J Cardiol. 1991. PMID: 2024591 Clinical Trial.

5

Usefulness of coronary angioplasty in asymptomatic patients.

Anderson HV, Talley JD, Black AJ, Roubin GS, Douglas JS Jr, King SB 3rd. Anderson HV, et al. Among authors: roubin gs. Am J Cardiol. 1990 Jan 1;65(1):35-9. doi: 10.1016/0002-9149(90)90022-s. Am J Cardiol. 1990. PMID: 2294679

6

Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.

Lembo NJ, Black AJ, Roubin GS, Wilentz JR, Mufson LH, Douglas JS Jr, King SB 3rd. Lembo NJ, et al. Among authors: roubin gs. Am J Cardiol. 1990 Feb 15;65(7):422-6. doi: 10.1016/0002-9149(90)90804-a. Am J Cardiol. 1990. PMID: 2407084 Clinical Trial.

7

Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.

Ellis SG, Roubin GS, King SB 3rd, Douglas JS Jr, Cox WR. Ellis SG, et al. Among authors: roubin gs. Am J Cardiol. 1989 Jan 1;63(1):30-4. doi: 10.1016/0002-9149(89)91071-0. Am J Cardiol. 1989. PMID: 2521196

8

Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.

Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB 3rd. Ellis SG, et al. Among authors: roubin gs. Am Heart J. 1989 Apr;117(4):777-82. doi: 10.1016/0002-8703(89)90612-1. Am Heart J. 1989. PMID: 2522716 Clinical Trial.

9

Primary angiographic success rates of percutaneous transluminal coronary angioplasty.

Anderson HV, Roubin GS, Leimgruber PP, Douglas JS Jr, King SB Jr, Gruentzig AR. Anderson HV, et al. Among authors: roubin gs. Am J Cardiol. 1985 Nov 1;56(12):712-7. doi: 10.1016/0002-9149(85)91121-x. Am J Cardiol. 1985. PMID: 2932902

10

Percutaneous coronary angioplasty: influence of operator experience on results.

Roubin GS, Douglas JS Jr, King SB 3rd. Roubin GS, et al. Am J Cardiol. 1986 Apr 1;57(10):873-4. doi: 10.1016/0002-9149(86)90630-2. Am J Cardiol. 1986. PMID: 2938466 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters